Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 4 minute read Technology Industry News Dev Information Technology (NSE: DEVIT) bags order from Alivus Lifesciences for Microsoft and Zoho licenses Dev IT wins ₹4.4 Cr order from Alivus Lifesciences, strengthening its enterprise software and pharma-sector footprint. Read how this deal supports its FY26 momentum. byPallavi MadhirajuJuly 3, 2025